. GSK3 inhibition modestly improves glycogen synthesis in AICARstimulated GS R582A/R582A muscles. EDL muscles from the indicated genotypes were incubated with either vehicle (0.2 % DMSO) or 3 μM CT99021 (GSK3 selective inhibitor) in the presence of buffer (resting) or 2 mM AICAR in KRB containing D-[U-14 C]glucose (5.5 mM) for 40 min. Glycogen synthesis was assayed as described in the Research Design and Methods.
. G6P does not significantly influence AMPK-mediated phosphorylation of Ser8 GS. Baculovirus-expressed muscle glycogen synthase (GS):GST-glycogenin-1 complex was dephosphorylated in vitro with recombinant PP1γ in 50 mM HEPES pH 7.4, 1 mM MnCl 2 , 0.1 mM EGTA and 1 mM DTT for 30 min at 30°C. PP1 was blocked using 1 μM microcystin-LR and the GS preparation was phosphorylated in vitro with recombinant AMPKα2β2γ 1 complex produced in E.coli activated with CaMKKβ (active AMPKα2β2γ 1 complex was donated by D. Grahame Hardie, University of Dundee). Briefly, 100 ng GS was incubated with 50 mM HEPES pH 7.4, 0.1 % (w/v) glycogen, 0.1 mM AMP, 10 mM MgCl 2 , 5 mU AMPK (assayed against AMARA peptide) and varying concentrations of G6P for 5 min at 30 °C. 5 mU recombinant protein kinase A (PKA) catalytic subunit (Promega) was used as a positive control. The reaction was started by the addition of 0.2 mM ATP, incubated for a further 20 min at 30°C and stopped by the addition of SDS sample buffer. Reactions were separated by SDS-PAGE and blotted for pSer8 and total GS. Results are representative of two independent experiments.
